NexGel Inc. is a specialty healthcare company that manufactures and sells high water content, electron beam cross-linked aqueous polymer hydrogels and gels primarily for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: NexGel, focused on producing ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, and CG labs. The company provides over-the-counter remedy solutions including blister and pain applications, alongside beauty and cosmetic solutions. NexGel Inc. also engages in contract manufacturing and maintains a portfolio of branded consumer products in health, wellness, and beauty categories. Recent initiatives include partnerships for launching enzyme supplements and acquisitions of international beauty brands to expand its consumer offerings. Additionally, it develops innovative products such as NEXDrape, an incise surgical drape for patients with impaired skin, and NEXDerm, an adhesive tape for securing medical devices. Founded in 2007 and headquartered in Langhorne, Pennsylvania, NexGel Inc. plays a key role in advancing hydrogel-based solutions across medical and personal care markets.